GLP-1 Access · Wegovy HD · Pricing Intelligence · Last verified: April 16, 2026

By The RX Index Editorial Team · Last verified: April 16, 2026 · Affiliate disclosure · Editorial standards

How to Get Wegovy HD Online in 2026

The short answer, before you scroll another inch

If you’re searching for how to get Wegovy HD online, here’s what’s real — and what’s misleading — as of April 16, 2026.

Wegovy HD (semaglutide 7.2 mg injection) was FDA-approved March 19, 2026 and launched nationwide April 7, 2026 through 70,000+ US pharmacies, NovoCare Pharmacy, and select telehealth providers. You can get it online. But there are three things most pages aren’t telling you clearly enough:

1. This is not a starter dose. Official Wegovy prescribing information says the 7.2 mg dose is for adults who have already been on Wegovy 2.4 mg for at least 4 weeks and need additional weight loss. If you haven’t been there yet, a legitimate prescriber won’t start you on HD.
2. The dependable self-pay number is $399/month. We verified this on NovoCare Pharmacy, WeightWatchers Med+, and GoodRx — the channels that publicly list Wegovy HD 7.2 mg and its price today. Most of the cheaper numbers on competing pages ($149, $199, $249) are for the Wegovy pill, starter-dose pens, or a lower monthly rate that requires a large upfront commitment.
3. Don’t assume insurance covers HD yet. NovoCare’s own coverage-check page currently states “Currently, no insurance coverage is available for Wegovy injection 7.2 mg” — even while the broader Wegovy savings page still advertises as-low-as-$25/month for Wegovy generally. That contradiction is a real trap if you pay for a telehealth membership expecting insurance to cover the medication.

First-screen route map

Sources: NovoCare Pharmacy pricing guide; WeightWatchers Med+ Wegovy page; GoodRx investor press release, April 15, 2026; Ro Body pricing page. All verified April 16, 2026.

Now, the rest of this page answers every follow-up that would otherwise send you back to search.

Can you actually get Wegovy HD online right now?

Yes. Wegovy HD launched nationwide on April 7, 2026. Novo Nordisk’s launch announcement confirms the 7.2 mg pen is available through 70,000+ US retail pharmacies (CVS, Costco, Walgreens, and others), NovoCare Pharmacy, and select telehealth providers. Supply is live, though individual pharmacy stock can still vary during the first weeks of a new product launch — if your local pharmacy doesn’t have it yet, ask them to order it or use NovoCare’s mail-order option.

Here’s the workflow, regardless of which route you pick:

1. A licensed clinician decides you’re an appropriate candidate for the step-up from 2.4 mg to 7.2 mg. This can be your PCP, an obesity medicine specialist, or a telehealth prescriber.
2. The prescription gets sent to a pharmacy. That pharmacy can be your local retail pharmacy, NovoCare Pharmacy (Novo’s own mail-order option), or a telehealth partner’s fulfillment pharmacy.
3. You pay and get the medication. Self-pay is $399/month through the verified channels. Commercial insurance math may change that — see the insurance section below.

What “select telehealth providers” actually means

Novo Nordisk named Ro, WeightWatchers Clinic, and LifeMD as launch partners for its March 31, 2026 multi-month subscription program, with Hims & Hers and Sesame Care coming online for subscription pricing. NovoCare’s own recognized-provider page lists LifeMD, Ro, Sesame, and WeightWatchers as recognized providers — meaning Novo acknowledges these providers for legitimate sourcing and patient support. Notably, Hims & Hers is not on NovoCare’s current recognized-provider list as of this verification, even though Hims’ investor page confirms Novo’s FDA-approved GLP-1s are now available through their platform.

Any US-licensed prescriber can write the script. But recognized/launch providers typically have the smoothest fulfillment path and access to Novo’s current self-pay pricing programs.

Who qualifies for Wegovy HD 7.2 mg?

Wegovy HD is not the dose most readers can start on. The prescribing information says 7.2 mg is for adults who want additional weight loss after being on Wegovy 2.4 mg for at least 4 weeks. If you haven’t been there yet, a legitimate prescriber will not start you directly on HD — and if anyone does, that’s a red flag about the provider, not a shortcut.

The three gates your clinician will check:

1. Age 18+. Wegovy HD is not approved for adolescents. The 1.7 mg and 2.4 mg doses of standard Wegovy injection are approved for ages 12 and up; HD is adults only.
2. BMI ≥30 (obesity), or BMI ≥27 (overweight) with at least one weight-related medical condition — type 2 diabetes, high blood pressure, high cholesterol, cardiovascular disease, or similar.
3. At least 4 weeks on Wegovy 2.4 mg, tolerated. This is the HD-specific gate. “Tolerated” means you made it four weeks on the maintenance dose without a serious adverse event or intolerance. Some nausea, some constipation, some fatigue — that’s normal and expected.

Contraindications (who should not use Wegovy at any dose): Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or serious hypersensitivity to semaglutide or any Wegovy ingredient.

Am I HD-ready? A quick self-check

What about time on compounded semaglutide?

The official HD label language specifies Wegovy 2.4 mg for at least 4 weeks — it does not say compounded semaglutide time qualifies. Compounded products are not FDA-reviewed, and the STEP UP trial used authentic Novo Nordisk semaglutide. If you’ve been on compounded semaglutide and want to step up to Wegovy HD, expect your clinician to start you on brand-name Wegovy 2.4 mg first for at least a month.

What does Wegovy HD actually cost online right now?

The dependable self-pay number is $399 per month. We verified this across the channels that currently publish Wegovy HD 7.2 mg pricing: NovoCare Pharmacy, WeightWatchers Med+, and GoodRx for Weight Loss. Most of the cheaper numbers on competing pages — $149, $199, $249 — are for the Wegovy pill, starter-dose Wegovy pens, or an effective monthly rate that demands a large upfront commitment. That pricing confusion is the single biggest trap for HD searchers.

“Advertised monthly number” vs. what it actually means

Effective monthly vs. real cash outlay — the part most pages skip

When WeightWatchers Med+ advertises ~$249/month effective for Wegovy HD, that number is real — but it requires paying $2,988 upfront for 12 months of medication, plus the separate Med+ membership fee. If you cancel mid-year, refunds are calculated at the $399/mo standard monthly rate, not the discounted bulk rate.

The difference — roughly $960 in first-year cost — is the real incentive behind the upfront commitment at WW. If you’re confident you’ll stay on HD for a year, the savings are significant. If you’re still evaluating whether HD works for you, month-to-month at $399 is the safer decision.

Does insurance cover Wegovy HD yet?

Treat this as unsettled until you verify on your actual plan. This is where the biggest trust gap sits on this entire query.

Here’s the contradiction, straight from Novo Nordisk’s own properties, both live as of April 16, 2026:

• NovoCare’s coverage-check page for Wegovy 7.2 mg says: “Currently, no insurance coverage is available for Wegovy injection 7.2 mg.”
• Novo’s general Wegovy savings page says: “Pay as little as $25, subject to a maximum savings of $100/month” with commercial insurance and the Wegovy Savings Offer.

Both are technically accurate — the savings card terms include HD in its list of eligible doses, but the vast majority of commercial plans have not yet added 7.2 mg to their formulary as of launch week. So the savings-card math works in theory. The insurance coverage that triggers it often doesn’t exist yet.

What this means for you today:

1. Don’t join a telehealth membership assuming insurance will cover HD at $25/mo. It probably won’t, yet.
2. Budget $399/mo self-pay as your baseline. If your plan adds HD to its formulary, that’s upside — use the savings card and you could drop to as little as $25. But don’t plan around the best case.
3. Use NovoCare’s free Coverage Lookup tool at wegovy.com before committing to any route. It’s free, fast, and tells you exactly what your plan is doing about HD.
4. If you’re betting on insurance, Ro is the strongest lane. Ro’s insurance concierge will file prior authorization requests, handle appeals, and if your plan denies coverage, you can either go cash-pay or cancel the Ro Body membership. That clean off-ramp is Ro’s real edge for insurance-first readers.

Prior authorization: what to expect

Most commercial plans that cover Wegovy require prior authorization (PA) — a clinical justification submitted to the insurer before the plan approves the fill. PA timelines vary by plan and can take up to 10 business days. Ro, LifeMD, and WeightWatchers Med+ all provide PA paperwork support as part of their service. If your PA is denied, your prescriber can file a peer-to-peer review or formal appeal.

Medicare, Medicaid, and government plans

Medicare: Medicare does not cover GLP-1 medications when prescribed for weight loss alone. Medicare may cover Wegovy when prescribed for cardiovascular risk reduction in adults with known heart disease and obesity or overweight. Formulary pickup of HD specifically is still in flux. Important update: CMS has announced that all formulations of Wegovy will be available to eligible Medicare beneficiaries through the Medicare GLP-1 Bridge program beginning July 1, 2026. If you’re a Medicare beneficiary, that date matters — check NovoCare’s Medicare navigation page or cms.gov for the latest.

Medicaid: State-by-state. Check your Medicaid plan’s drug formulary. Savings card excludes government beneficiaries regardless.

HSA/FSA: Wegovy HD is generally eligible as an HSA/FSA medical expense when prescribed. Some plan administrators may require specific documentation, so confirm with your plan before counting on reimbursement. See our Wegovy HSA/FSA guide for more detail.

Which online route is best for your situation?

It depends on three things: whether you already have an HD prescription, whether you want help with insurance, and how you feel about upfront commitments.

The Verified Wegovy HD Online Access Matrix — April 16, 2026

Sources: NovoCare Pharmacy pricing guide; NovoCare recognized-provider page; Novo Nordisk April 7, 2026 launch announcement; Novo March 31, 2026 subscription announcement; WeightWatchers Med+ Wegovy page; GoodRx April 15, 2026 investor press release; Ro Body pricing page; Sesame medication page; LifeMD weight-management page; Hims investor announcement; Walgreens Wegovy page. All verified April 16, 2026.

WeightWatchers Med+ for Wegovy HD — our primary telehealth pick

Why it wins this specific query: WeightWatchers Med+ is the only major telehealth program we found that publicly names “Wegovy HD (7.2 mg pen)” on its live Wegovy product page and publishes both the standard monthly price and the 12-month effective rate for HD specifically. That transparency — combined with CenterWell Pharmacy fulfillment, recognition on NovoCare’s provider list, and clinical staff trained on GLP-1 care — is why we’re recommending it first for HD-ready readers who still need a prescriber.

How it’s priced:

• Standard monthly (no commitment): $399/mo medication + Med+ membership
• 12-month medication commitment: ~$249/mo effective — which is $2,988 paid upfront for a year of Wegovy HD
• Med+ membership: $25 for the first month, then $74/month on the 12-month commitment plan
• Delivery: Through CenterWell Pharmacy; included
• Insurance: Med+ will work with your commercial plan on coverage

What’s included beyond the medication: licensed clinician visits, registered dietitian access, concierge support, and the WeightWatchers behavioral tracking platform.

The honest catch

WeightWatchers Med+ does NOT have the cheapest commitment-free HD path. If you already have a Wegovy HD prescription from your own clinician, NovoCare is cleaner — $399/month flat, zero membership fee, direct from Novo Nordisk. And if insurance paperwork is your actual blocker, Ro’s coverage concierge is the stronger lane.

But because WW publishes explicit “Wegovy HD (7.2 mg pen)” language and HD-specific pricing on its public page today, it gives HD-ready telehealth shoppers the clearest proof that your specific medication is on the menu. For a launch-week product where several competitor platforms still reference only 2.4 mg, that transparency matters.

Who it’s right for

• You’re on Wegovy 2.4 mg and ready to step up to HD
• You want the WeightWatchers program (behavioral coaching, dietitian, app tracking) alongside your GLP-1 care
• You’re planning to stay on HD for at least a year and want the lowest effective monthly rate
• You can comfortably put $2,988 upfront for the year’s medication

Who should skip WW Med+

• You just want a prescription and a pharmacy fill → NovoCare is simpler
• You’re still evaluating whether HD is right for you → don’t lock into a year of medication before you know
• You don’t want the WeightWatchers program → you’d be paying for something you won’t use

“Weight Watchers Med+ is a gamechanger. You not only get your meds from a licensed clinician, but you have access to a dietician and concierge support.” — Trustpilot review, April 2026

Individual experience. We cite this as an indicator of program structure (clinician + dietitian + concierge access), not as proof of weight-loss outcomes.

NovoCare Pharmacy — the simplest route if you already have a prescription

Why it’s the cleanest fill-only option: NovoCare Pharmacy is Novo Nordisk’s own direct-to-patient mail-order pharmacy. It publishes the $399/month self-pay price for Wegovy HD, charges no telehealth membership fee, and ships nationwide. If your clinician is willing to write the HD script, this is the lowest-friction path available.

How it works

1. Your clinician sends the Wegovy HD prescription electronically to NovoCare Pharmacy.
2. You create a NovoCare account and confirm your shipping address.
3. You pay $399/month self-pay (or your insurance copay if your plan has HD on its formulary — rare as of this week).
4. Medication ships.

The single weakness: You still need a prescriber. If you don’t have one who’s comfortable making the 2.4 mg → 7.2 mg step-up call, you’ll need to establish care somewhere first — and by the time you’ve done that, a telehealth launch partner may be more efficient than NovoCare plus a separate outside visit.

Who it’s right for

• You’re already established with a clinician who prescribes your Wegovy 2.4 mg
• You’ve hit the 4-week mark and your clinician agrees HD is appropriate
• You don’t want another telehealth membership fee
• You want the cleanest possible price with no extras

Ro Body — best when paperwork is the blocker

Why Ro is on this list even though its public HD pricing isn’t clear: Ro is a NovoCare-recognized provider and one of Novo’s named subscription launch partners. But Ro’s real edge for this query isn’t the HD price — it’s the insurance infrastructure. Ro’s concierge will fight coverage battles with your plan, file prior authorization paperwork, handle appeals, and if your insurer ultimately denies HD, you can continue cash-pay or cancel the Ro Body membership. That off-ramp — plus the PA support — is genuinely useful if insurance is your main concern.

How Ro Body is priced (verified April 16, 2026):

• Membership: $39 for the first month, then $149/mo month-to-month, or as low as $74/mo on the annual prepay plan ($888 upfront for the year)
• Standard Wegovy pen medication: Starts at $199/mo on intro pricing for 0.25 mg and 0.5 mg, then $349/mo. Multi-month subscription rates ($249–$329/mo) also available through Ro for standard Wegovy pen doses.
• Wegovy HD 7.2 mg medication: [NEEDS VERIFICATION] — Ro’s public pricing page lists standard Wegovy pen doses but does not clearly publish a 7.2 mg price as of April 16, 2026. Novo’s announcement confirms Ro will carry HD. Before committing to a Ro membership, confirm HD pricing with Ro support directly.
• Insurance concierge: Included with Ro Body. Ro will coordinate with commercial insurance, file PA requests, and process appeals.

The honest catch

Ro does NOT give the clearest public HD pricing proof right now. If you want transparent, published-today 7.2 mg pricing before you spend a dollar, WeightWatchers Med+ is the stronger lane.

But if your real bottleneck is insurance — you believe your plan should cover Wegovy HD and you’re dreading the prior-auth fight — Ro’s coverage concierge is the single strongest service in this market for that exact problem. If everything falls through, you cancel.

“Fast, thorough, and helpful through the process of starting a new medication.” — Trustpilot review, April 2026

Individual experience. Ro’s Trustpilot page also includes cost- and billing-related complaints — one reason we emphasize up-front pricing clarity throughout this page.

Other routes worth knowing

These are legitimate but narrower fits for this specific query. If the three primary routes above don’t work for you, scan this section.

GoodRx for Weight Loss

Wegovy HD was added to GoodRx’s self-pay program on April 15, 2026, at $399/month (with two-month and three-month bundles at $798 and $1,197 respectively). GoodRx for Weight Loss is a $39/month subscription-based care program — you meet with a licensed clinician, complete an eligibility assessment, and receive a prescription if appropriate. Best for: a self-pay shopper who wants a transparent, newer benchmark with local pharmacy pickup options. Note: GoodRx is not on NovoCare’s current recognized-provider list, though the HD launch partnership is directly between GoodRx and Novo.

Sesame Care (Success by Sesame)

Sesame is NovoCare-recognized and named in Novo’s March 31, 2026 subscription expansion as “coming soon.” Success by Sesame starts at $59/month on an annual plan — the lowest membership fee of any FDA-approved telehealth lane we surveyed. Sesame already prescribes standard Wegovy. Best for: a cost-sensitive reader in the FDA-approved brand lane who’s willing to verify HD fulfillment directly with Sesame support. Catch: No public Wegovy HD-specific price found as of this verification [NEEDS VERIFICATION].

LifeMD

LifeMD is a NovoCare-recognized provider and named Novo subscription launch partner. Their weight-management program includes lab work, a $149/mo program fee (first month discounted to $75), and standard Wegovy pen medication starting at $199/mo on intro dosing. Best for: readers who want a clinical onboarding flow with blood work. Catch: No public Wegovy HD-specific price found [NEEDS VERIFICATION]. Program fee stacks on top of medication cost.

Hims & Hers

Hims & Hers’ live public pages now say “high dose available” and list a 0.25–7.2 mg dosage range, and Hims’ investor page confirms Novo’s FDA-approved GLP-1s are available through the platform. Brand Wegovy on Hims/Hers public pages starts at $199/mo — lower doses likely drive that advertised number. Best for: readers who want a mainstream app-first experience once HD pricing and fulfillment are fully confirmed. Catch: HD-specific pricing [NEEDS VERIFICATION]; not on NovoCare’s current recognized-provider list; state availability varies.

Retail pharmacies (CVS, Costco, Walgreens, and others)

Any major US retail pharmacy can fill a Wegovy HD prescription with the Wegovy Savings Offer or at the $399/mo self-pay price. Best for: readers who already have a prescriber and prefer their local pharmacy.

Should you step up to Wegovy HD from 2.4 mg?

The case for stepping up is real — and so is the tradeoff. In Novo’s STEP UP phase 3b trial, adults with obesity taking Wegovy HD for 72 weeks lost a mean of 18.7% of body weight (the real-world “treatment policy” estimate) or about 20.7% (the idealized estimate assuming everyone stayed on treatment). For comparison, Wegovy 2.4 mg in the STEP 1 trial produced ~14.9% mean weight loss. About 31% of HD patients hit ≥25% weight loss — more than double the 15.3% rate on 2.4 mg.

But side effects scale with dose. The single biggest tradeoff is dysesthesia — altered skin sensation described as sensitivity, burning, tingling, or electric-shock-like feelings. 22% of HD patients reported dysesthesia, versus 6% on 2.4 mg and 0.3% on placebo. That’s a nearly 4× jump. In STEP UP, most cases resolved on their own or with dose reduction, and treatment discontinuation from adverse events was similar on both active doses (~5%).

Side-by-side: Wegovy 2.4 mg vs. Wegovy HD 7.2 mg

Sources: FDA press releases; STEP UP (Lancet Diabetes & Endocrinology, Nov 2025); STEP 1 (NEJM, 2021); Novo Nordisk prescribing information; NovoCare pricing.

Good candidate for stepping up

• Plateaued on 2.4 mg and BMI is still elevated
• Tolerated 2.4 mg reasonably well
• You and your clinician both agree additional weight loss is valuable
• No existing dysesthesia or nerve-sensation issues on 2.4 mg
• Can absorb the $50/mo premium (or insurance is expected to cover)

Should probably stay at 2.4 mg

• At or near your weight goal on 2.4 mg
• Already experiencing dysesthesia or skin-sensation issues
• Had severe GI intolerance during titration
• Planning pregnancy within two months (stop Wegovy entirely)
• Budget pressure and no insurance coverage path for HD

What are the real side effects of Wegovy HD?

The side-effect profile at 7.2 mg is known and should not be minimized. The most common adverse reactions: nausea, vomiting, dysesthesia, constipation, abdominal pain, fatigue, headache, dizziness, hair loss, and flatulence. The dose-related increases vs. 2.4 mg are GI symptoms (>70% of patients at some point) and dysesthesia (22% vs. 6%).

The boxed warning (unchanged from lower doses): Wegovy carries an FDA boxed warning for thyroid C-cell tumors observed in rodents. Human relevance is unknown. Wegovy is contraindicated in patients with personal or family history of MTC or MEN 2.

Additional warnings from the prescribing information:

• Acute pancreatitis: persistent, severe abdominal pain warrants immediate medical attention
• Gallbladder disease: increased risk
• Acute kidney injury: especially from dehydration due to vomiting or diarrhea — stay hydrated
• Hypoglycemia: risk increased when Wegovy is used with insulin or a sulfonylurea
• Diabetic retinopathy: patients with known history should be monitored
• Serious allergic reactions: including anaphylaxis and angioedema
• Pregnancy: stop Wegovy at least 2 months before planned conception

Dysesthesia — what patients describe

The altered skin sensation most commonly described in STEP UP includes unusual skin sensitivity, burning or tingling, a sensation of pressure or touch that shouldn’t be there, and brief shock-like feelings. The FDA noted these occurred more frequently at the higher dose and is continuing to investigate. Most cases in the trial resolved spontaneously or after a dose reduction from 7.2 mg to 2.4 mg.

If you already have neuropathy, chronic skin pain, or a nerve-sensation condition, bring this up with your prescriber before stepping up. It’s not an automatic disqualifier, but it warrants a direct conversation.

When Wegovy HD isn’t the right answer

• If GI side effects were bad on 2.4 mg: Consider Zepbound (tirzepatide), a dual GLP-1/GIP receptor agonist with a different side-effect profile.
• If you want to avoid weekly injections: Consider the Wegovy pill (oral semaglutide 25 mg), FDA-approved December 22, 2025, launched January 5, 2026.
• If cost is the driver: Compounded semaglutide is a different product and regulatory pathway — not a legal step-up to 7.2 mg. But for patients who can’t afford brand Wegovy, it’s a different path at a different price point. Current FDA guidance notes the semaglutide injection shortage has been resolved and reiterates legal restrictions on compounding essentially copies of commercially available drugs.

What if I’m not HD-ready yet?

If you haven’t been on Wegovy 2.4 mg for at least 4 weeks, a legitimate prescriber will not start you on HD. That’s the label. Don’t pay for a telehealth membership hoping they’ll wave you through — they won’t, and if they do, that’s a red flag.

Start standard Wegovy and titrate up

The standard Wegovy titration schedule:

• Weeks 1–4: 0.25 mg
• Weeks 5–8: 0.5 mg
• Weeks 9–12: 1.0 mg
• Weeks 13–16: 1.7 mg
• Week 17+: 2.4 mg maintenance

You’re eligible for the HD conversation 4 weeks after reaching 2.4 mg — roughly 20–24 weeks from your first dose if you titrate on schedule. Self-pay today: first 2 months at $199/mo for 0.25 mg and 0.5 mg (Novo intro offer, through June 30, 2026), then $349/mo for subsequent doses through 2.4 mg.

Consider Zepbound (tirzepatide)

If you haven’t committed to the Wegovy brand yet, Zepbound uses a different mechanism (dual GLP-1/GIP) and head-to-head trial data suggests it can produce more weight loss than Wegovy 2.4 mg. Zepbound pricing through Ro and LillyDirect is competitive. See our GLP-1 comparison guides for more detail.

Consider the Wegovy pill

If injections are a dealbreaker, Wegovy is available as a once-daily 25 mg oral tablet (FDA-approved December 22, 2025, launched January 5, 2026). Different dosing, different cost ($149–$299/mo cash), no 7.2 mg equivalent dose. See our oral GLP-1 HSA/FSA guide for details.

How to spot Wegovy HD scams

Buy Wegovy HD only through NovoCare Pharmacy, Novo Nordisk’s recognized telehealth providers, or licensed US retail pharmacies. Authentic Wegovy HD ships as a single-dose pre-filled pen marked 7.2 mg. If any of the following apply, you’re not dealing with the real product:

• The price is dramatically below $399/month self-pay. Novo sets the self-pay floor. “Wegovy HD for $129/month” is not Wegovy HD.
• It’s offered without a prescription. Wegovy HD is prescription-only in the US, period.
• It arrives as vials, powder, or loose preparations. All Wegovy doses ship only as pre-filled pens from Novo Nordisk. Vials or reconstitution kits are compounded semaglutide, not Wegovy.
• The seller is an international online pharmacy you can’t verify. The FDA has issued warnings about counterfeit semaglutide in the US supply chain. If you can’t verify the pharmacy on NABP’s Safe.Pharmacy or the FDA’s approved online pharmacy list, don’t trust the product.

If you’ve already received a product you suspect is counterfeit, stop using it, save the packaging, and report it to your healthcare provider plus the FDA’s MedWatch program.

What we actually verified on April 16, 2026

• ✅FDA approval date for Wegovy HD: March 19, 2026. Source: FDA press announcement.
• ✅Nationwide launch date: April 7, 2026. Source: Novo Nordisk press release.
• ✅Self-pay price (NovoCare): $399/month for Wegovy HD 7.2 mg. Source: NovoCare pricing guide PDF and novocare.com.
• ✅Self-pay price (GoodRx): $399/mo; $798/2 mo; $1,197/3 mo. Source: GoodRx investor press release, April 15, 2026.
• ✅WeightWatchers Med+ HD pricing: $399/mo standard; ~$249/mo effective with 12-month medication commitment ($2,988 upfront). Source: weightwatchers.com Wegovy page.
• ✅Ro Body membership pricing: $39 first month; $149/mo monthly; as low as $74/mo annual prepay. Source: ro.co/weight-loss/pricing.
• ✅Wegovy HD 4-week prerequisite on 2.4 mg: Confirmed in Novo Nordisk prescribing information and official FAQ.
• ✅Novo multi-month subscription exclusion of HD: Novo's March 31, 2026 press release states "Wegovy HD (semaglutide) injection 7.2 mg will be added at a later date."
• ✅NovoCare recognized providers: LifeMD, Ro, Sesame, and WeightWatchers. Hims & Hers not on current list. Source: NovoCare find-a-doctor telehealth page.
• ✅STEP UP trial data: Mean weight loss 18.7% (treatment policy), 20.7% (idealized), 31.2% achieving ≥25% loss. Source: Wharton et al., Lancet Diabetes & Endocrinology, Nov 2025.
• ✅Dysesthesia rate: 22% on HD, 6% on 2.4 mg, 0.3% placebo. Source: STEP UP trial; FDA press release; prescribing information.
• ✅Medicare GLP-1 Bridge: CMS announced all Wegovy formulations available to eligible Medicare beneficiaries beginning July 1, 2026. Source: cms.gov.

Next scheduled re-verification: May 16, 2026. If you see something on a provider page that doesn’t match what we’ve published here, let us know at corrections@therxindex.com.

Frequently asked questions about getting Wegovy HD online